Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07792434 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nociplastic Pain in Patients Diagnosed With Subacromial Pain Syndrome (SAPS)

Study acronym: The NAP SAPS
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date pushed from Sep 15, 2026 to Oct 19, 2026
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 5 of 5 entries
  2. Eligibility criteria revised
    • Study description revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Vejle Hospital
29 trials monitored
See 2 trials at risk
The goal of this cross-sectional study is to estimate the prevalence of the nociplastic pain phenotype, according to the IASP clinical criteria, among patients diagnosed with SubAcromial Pain Syndrome (SAPS). The main question it aims to answer is: What is the prevalence of the nociplastic pain phenotype in patients diagnosed with SAPS in an outpatient clinic? Primary outcome: Proportion of patients with SAPS meeting the IASP criteria for nociplastic pain.
Trial Details
NCT Number NCT07792434
Lead Sponsor Vejle Hospital
Conditions
(from sponsor)		 Subacromial Pain Syndrome, Rotator Cuff Related Shoulder Pain, Shoulder Pain, Shoulder Impingement Syndrome, SAPS
Related terms Chronic Pain, Musculoskeletal Pain, Nociplastic Pain, Shoulder Impingement Syndrome, Shoulder Pain
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov